Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Authors / Dorina Kotoni

Dorina Kotoni

Dorina Kotoni is Analytical Expert and Principal Scientist at Novartis, Basel, Switzerland. After gaining an MS in Pharmaceutical Chemistry, Dorina completed her PhD in Pharmaceutical Sciences at the Sapienza University of Rome. First as a PhD student and later as a Post-Doc Fellow in Prof. Gasparrini ’s lab, Dorina’s research focused on the preparation and characterization of chiral stationary phases for enantioselective UHPLC and UHPSFC, as well as on the development of new HILIC materials for rapid speed analysis of carbohydrates. Her interest in both chiral and achiral UHPLC columns, has l ed to a more in-depth study of the parameters influencing chromatographic performance in UHPLC. Dorina is currently working in Novartis with a focus on the HPLC to UHPLC transition and HIL IC method development.

  • Contributions
Techniques & Tools Pharma and Biopharma

The Search for the Ideal Detector

February 24, 2016

Will aerosol-based detectors ever meet all the needs of the pharmaceutical industry?

1 min read

The Search for the Ideal Detector

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.